FSH: How to Interpret Your Result

What FSH Actually Measures

Follicle-stimulating hormone is a glycoprotein secreted by gonadotroph cells in the anterior pituitary gland. Its release is governed by gonadotropin-releasing hormone (GnRH) from the hypothalamus, which itself pulses every 60 to 120 minutes 1. FSH acts directly on ovarian granulosa cells in women and on Sertoli cells in men.

The Hypothalamic-Pituitary-Gonadal Axis

GnRH stimulates the pituitary to release both FSH and luteinizing hormone (LH). Estradiol and inhibin B from the ovaries feed back to suppress FSH secretion, creating a tightly regulated loop 2. In men, inhibin B from Sertoli cells provides the primary negative feedback signal for FSH, while testosterone suppresses LH 3.

Why Pulsatility Matters for Interpretation

Because GnRH is secreted in pulses, FSH concentrations fluctuate throughout the day. A single blood draw captures one point in that wave. The Endocrine Society recommends drawing FSH in the early morning (0700 to 1000) and, for premenopausal women, on cycle day 2, 3, or 4, when the feedback environment is most standardized 4.

Normal FSH Ranges by Age and Sex

Reference intervals vary by assay platform. The values below reflect immunoassay ranges reported across major reference laboratories and endorsed in Endocrine Society clinical practice guidelines 4.

Women: Menstrual Cycle Phases

• Follicular phase (day 2 to 4): 3.5 to 12.5 mIU/mL
• Midcycle surge: 4.7 to 21.5 mIU/mL
• Luteal phase: 1.7 to 7.7 mIU/mL
• Postmenopausal: 25.8 to 134.8 mIU/mL

A day-3 FSH above 10 mIU/mL is a well-established threshold for concern about ovarian reserve. The ASRM Committee Opinion states that basal FSH above 10 mIU/mL, especially when paired with estradiol above 60 to 80 pg/mL, is associated with poor IVF response 5.

Men

Adult male FSH ranges from 1.5 to 12.4 mIU/mL. Values persistently above 12 mIU/mL suggest primary testicular failure. Values below 1.0 mIU/mL, paired with low testosterone, indicate hypogonadotropic hypogonadism and warrant pituitary MRI 6.

Children and Adolescents

FSH is low (typically <0.1 to 2.0 mIU/mL) in prepubertal children. Rising FSH is one of the earliest hormonal markers of puberty onset. Premature elevation may signal precocious puberty and should prompt referral to pediatric endocrinology 7.

What High FSH Means

An elevated FSH reflects the pituitary working harder because its target gland is underperforming. The pituitary senses low estradiol or low inhibin B, removes the brake on gonadotroph output, and FSH rises 2.

High FSH in Women

The most common cause of persistently elevated FSH in women over 40 is the menopausal transition. The Study of Women's Health Across the Nation (SWAN) demonstrated that FSH begins rising roughly 2 to 6 years before the final menstrual period, and a single value above 25 mIU/mL in a woman with irregular cycles has a positive predictive value exceeding 80% for the onset of menopause within 4 years 8.

In women under 40, persistently elevated FSH above 25 mIU/mL measured on two occasions at least one month apart meets the biochemical criterion for premature ovarian insufficiency (POI). The Endocrine Society's 2023 guideline on POI recommends karyotyping and FMR1 premutation screening in all women diagnosed before age 40 9.

Other causes of elevated FSH in women include gonadal dysgenesis (Turner syndrome), prior ovarian surgery, chemotherapy or pelvic radiation exposure, and autoimmune oophoritis.

High FSH in Men

Elevated FSH in men (above 12 to 15 mIU/mL, lab-dependent) typically reflects Sertoli cell dysfunction. This appears most often in Klinefelter syndrome (47,XXY), post-chemotherapy damage, prior orchitis, or cryptorchidism. The AUA/ASRM male infertility guideline recommends semen analysis alongside FSH to distinguish between secretory and obstructive causes of azoospermia 10.

A man with azoospermia and FSH more than twice the upper normal limit has a high probability of severe spermatogenic failure. Testicular sperm extraction (TESE) retrieval rates in this group average 30 to 50%, per data from a 2020 meta-analysis 11.

What Low FSH Means

Low FSH signals that the pituitary is not sending adequate stimulation to the gonads. The cause may sit in the pituitary itself or upstream in the hypothalamus.

Hypogonadotropic Hypogonadism

FSH below 1.0 mIU/mL, combined with low LH and low sex steroids, defines hypogonadotropic hypogonadism. Congenital forms include Kallmann syndrome (with anosmia) and idiopathic hypogonadotropic hypogonadism (IHH). Acquired causes include pituitary tumors (especially prolactinomas), infiltrative disease, head trauma, and chronic opioid use 12.

The Endocrine Society recommends pituitary MRI and prolactin measurement in any patient with confirmed central hypogonadism 6. Prolactinomas are the most common pituitary tumors, and dopamine agonist therapy (cabergoline) normalizes both prolactin and gonadotropin secretion in over 90% of microadenomas 13.

Functional Suppression

Functional hypothalamic amenorrhea (FHA) is a reversible cause of low FSH and LH in premenopausal women. Excessive exercise, caloric restriction, or psychological stress can suppress GnRH pulsatility enough to shut down the reproductive axis 14. The Endocrine Society guideline on FHA emphasizes that diagnosis requires excluding organic disease, thyroid dysfunction, and hyperprolactinemia before attributing low gonadotropins to energy deficit 14.

Exogenous testosterone or anabolic steroid use in men suppresses FSH and LH through negative feedback, often to undetectable levels. This is the most common cause of low FSH encountered in men's health clinics 15.

The FSH-Estradiol Pairing: Why Both Numbers Matter

Reading FSH alone without estradiol is like checking half a thermostat. A "normal" day-3 FSH of 8 mIU/mL looks reassuring. But if the paired estradiol is 75 pg/mL, the elevated estradiol is already suppressing FSH, masking a declining ovarian reserve. The true FSH, without that early estradiol rise, would be higher 5.

The CCCT and Modern Alternatives

The clomiphene citrate challenge test (CCCT) was once the standard provocative test for ovarian reserve. Patients took 100 mg of clomiphene on cycle days 5 to 9 and measured FSH on day 3 and day 10. A day-10 FSH above 10 mIU/mL predicted poor response. However, the ASRM now considers AMH and antral follicle count (AFC) by ultrasound to be more reliable than stimulated FSH testing 16. The CCCT has largely been retired from practice.

FSH Plus AMH: The Full Ovarian Reserve Picture

AMH (anti-Müllerian hormone) is produced by small antral follicles and reflects the remaining follicle pool directly. Unlike FSH, AMH does not fluctuate with the menstrual cycle and can be drawn on any day. A 2021 individual-patient-data meta-analysis (N=17,146) found that AMH combined with AFC predicted poor ovarian response (fewer than 4 oocytes) with an AUC of 0.78, outperforming basal FSH alone (AUC 0.69) 17.

How to Lower Elevated FSH

Lowering FSH is not the therapeutic goal. A high FSH is a signal, not the disease. Suppressing FSH with hormonal contraceptives or estrogen therapy will bring the number down on paper but does not restore ovarian reserve or reverse testicular failure.

When Lowering the Number Has Clinical Utility

In specific fertility protocols, GnRH agonist or antagonist pretreatment can transiently suppress FSH before controlled ovarian stimulation. This "reset" allows the clinician to administer exogenous gonadotropins in calibrated doses. A 2019 Cochrane review found that GnRH antagonist protocols reduced the risk of ovarian hyperstimulation syndrome (OHSS) by 50% compared with agonist long protocols, with no difference in live-birth rates 18.

Lifestyle Factors That Support the HPG Axis

For functional causes (FHA, stress-related suppression), restoring energy availability is the primary intervention. Weight restoration to within 90% of ideal body weight and reduction of exercise volume below 5 to 7 hours per week are associated with return of menses in approximately 70% of women with FHA within 6 to 12 months 14.

In men using exogenous testosterone, discontinuing TRT allows the HPG axis to recover, though complete recovery of spermatogenesis can take 6 to 24 months. Adjunctive clomiphene citrate (25 to 50 mg daily off-label) or human chorionic gonadotropin (hCG) can accelerate gonadotropin recovery 15.

How to Raise Low FSH

A truly low FSH needs cause-directed therapy, not a supplement to "boost" the number.

Treating the Underlying Cause

Prolactinoma causing low FSH responds to cabergoline 0.25 to 1.0 mg twice weekly, with normalization of gonadotropins in 80 to 90% of microprolactinomas within 3 to 6 months 13. For IHH or Kallmann syndrome, pulsatile GnRH therapy (delivered via a subcutaneous pump) can restore physiologic FSH and LH secretion and induce fertility. A 2019 series showed sperm concentrations above 1 million/mL in 77% of treated men by 12 months 19.

Off-Label Approaches in Men's Health

Enclomiphene and clomiphene citrate block estrogen receptors at the hypothalamus, reducing negative feedback and raising FSH and LH. In hypogonadal men, clomiphene 25 mg daily raised FSH by a mean of 3.8 mIU/mL and total testosterone by approximately 250 ng/dL over 12 weeks in a retrospective series of 86 patients 20. This approach preserves spermatogenesis, unlike exogenous testosterone.

FSH in the Menopausal Transition

The North American Menopause Society (NAMS) 2022 position statement notes that FSH testing is generally not required to diagnose menopause in women over 45 with 12 months of amenorrhea 21. Clinical criteria alone are sufficient.

When FSH Testing Adds Value in Perimenopause

FSH becomes diagnostically useful in three scenarios during midlife:

1. Women aged 40 to 45 with irregular cycles where the differential includes thyroid disease, PCOS, or pregnancy. An FSH above 25 mIU/mL, repeated and confirmed, supports a menopausal etiology.
2. Women who have had a hysterectomy (uterus removed, ovaries retained) and lack the amenorrhea criterion. FSH above 30 mIU/mL confirms ovarian failure.
3. Women on hormonal contraception who want to know if they have reached menopause. The pill suppresses FSH, so testing requires a 2-to-4-week washout before drawing the sample.

FSH Variability in Perimenopause

During the menopausal transition, FSH can swing from 15 to 80 mIU/mL within a single menstrual cycle. The SWAN cohort documented FSH coefficient of variation exceeding 30% year-to-year in late-transition women 8. A single "normal" FSH does not rule out perimenopause.

Medications and Conditions That Alter FSH Results

Several commonly prescribed drugs affect FSH values independent of gonadal function. Knowing these confounders prevents misinterpretation.

Drugs That Suppress FSH

• Combined oral contraceptives and estrogen patches suppress GnRH pulsatility, lowering FSH to 1 to 4 mIU/mL.
• GnRH agonists (leuprolide, goserelin) cause initial FSH flare followed by deep suppression within 2 to 4 weeks 22.
• Exogenous testosterone and anabolic steroids suppress FSH through hypothalamic feedback 15.
• High-dose biotin (above 5 mg/day) interferes with streptavidin-biotin immunoassays, producing falsely low FSH on some platforms 23. The FDA issued a safety communication in 2017 warning about biotin interference in laboratory tests. Patients should stop biotin supplementation 48 to 72 hours before testing.

Drugs That Raise FSH

• Clomiphene and enclomiphene raise FSH by blocking hypothalamic estrogen receptors 20.
• Aromatase inhibitors (letrozole, anastrozole) lower estradiol, removing negative feedback and raising FSH.

Medical Conditions Affecting FSH

Chronic kidney disease (CKD stage 4 to 5) impairs gonadotropin clearance, often producing mildly elevated FSH without true gonadal failure. Severe liver disease alters sex hormone-binding globulin (SHBG) and estradiol metabolism, complicating FSH interpretation. Untreated hypothyroidism can raise prolactin mildly, which may suppress FSH through dopaminergic pathways.

Retesting Protocol and Clinical Action Thresholds

One abnormal FSH is not a diagnosis. Repeat testing is the standard.

When to Retest

• Mildly elevated day-3 FSH (10 to 15 mIU/mL): Repeat on the next cycle's day 3, paired with estradiol and AMH.
• FSH above 25 mIU/mL in a woman under 40: Repeat in 4 to 6 weeks. If confirmed, begin POI workup (karyotype, FMR1, adrenal antibodies, thyroid panel) per Endocrine Society guidance 9.
• Low FSH (<1.0 mIU/mL) with low sex steroids: Obtain prolactin, IGF-1, cortisol, free T4, and pituitary MRI 6.
• Male infertility evaluation: FSH, LH, total testosterone, semen analysis. If FSH is elevated with azoospermia, genetic testing (Y-chromosome microdeletions, karyotype) is recommended before TESE 10.

Action Thresholds Summary

| FSH Value | Context | Next Step | |---|---|---| | <1.0 mIU/mL | Either sex, low sex steroids | Pituitary MRI, prolactin | | 10 to 15 mIU/mL | Day-3, premenopausal | Repeat with estradiol and AMH | | >25 mIU/mL | Woman <40 | POI workup | | >25 mIU/mL | Woman 40 to 45, irregular cycles | Confirms menopausal transition | | >12 mIU/mL | Man with infertility | Semen analysis, genetic testing |

Patients receiving FSH results through HealthRX panels should share their full panel (FSH, LH, estradiol, AMH or testosterone) with their prescribing clinician for interpretation specific to their clinical context.